Doxorubicin alone or with ifosfamide for treating soft tissue sarcoma?

(European Organisation for Research and Treatment of Cancer) An EORTC study published in The Lancet Oncology does not support administration of intensified doxorubicin and ifosfamide for palliation of advanced soft tissue sarcoma, unless the objective is to shrink the tumor.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news